Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report providing unrivalled insight into future of industry Pharmaceutical Investing
SKYRIZI® Receives FDA Approval as the First and Only Specific Interleukin-23 to Treat Moderately to Severely Active Crohn's Disease in Adults Pharmaceutical Investing
Bristol Myers Squibb Elects Deepak L. Bhatt, M.D., M.P.H. to Board of Directors Pharmaceutical Investing
The Gummy Project Begins Journey to Become a Household Brand Across North America-One Gummy at a Time Biotech Investing
The Gummy Project Selected to Be Supplier of Gummy Products for Flair Airlines with New Partnership Biotech Investing
